Induction of apoptosis by evodiamine involves both activation of mitotic arrest and mitotic slippage

Oncology Reports

Volumn 26, Issue 6, 2011, Pages 1447-1455

  Zhu, Li Hong ^a,c   Bi, Wei ^b   Liu, Xiao Dong ^c   Li, Jie Fen ^c   Wu, Ying Ya ^c   Du, Biao Yan ^c   Tan, Yu Hui ^c  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Apoptosis; CyclinB1; Evodiamine; Mitotic arrest; Mitotic slippage

Indexed keywords

CYCLIN B1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; EVODIAMINE;

ANAPHASE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL SURVIVAL; CELL SYNCHRONIZATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METAPHASE; MITOSIS; MITOSIS INHIBITION; MITOTIC SLIPPAGE; PRIORITY JOURNAL; STOMACH CANCER;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CYCLIN B1; CYCLIN E; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; HUMANS; MITOSIS; QUINAZOLINES;

EID: 80053509723     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1444     Document Type: Article

References (36)

1. Wu CL, Hung CR, Chang FY, Lin LC, Pau KY and Wang PS: Effects of evodiamine on gastrointestinal motility in male rats. Eur J Pharmacol 457: 169-176, 2002.
2. Chiou WF, Chou CJ, Shum AYC and Chen CF: The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries: mode of action. Eur J Pharmacol 215: 277-283, 1992.
3. Rang WQ, Du YH, Hu CP, et al: Protective effects of evodiamine on myocardial ischemia-reperfusion injury in rats. Planta Med 70: 1140-1143, 2004.
4. Tang W and Eisenbrand G (eds): Evodia rutaecarpa (Juss) Benth. In: Chinese Drugs of Plant Origin. Springer-Verlag, Berlin, pp509-514, 1992.
5. Fei XF, Wang BX, Li TJ, et al: Evodiamine, a constituent of Evodiae Fructus, induces anti-proliferating effects in tumor cells. Cancer Sci 94: 92-98, 2003. (Pubitemid 36575865)
6. Kan SF, Yu CH, Pu HF, Hsu JM, Chen MJ and Wang PS: Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3. J Cell Biochem 101: 44-56, 2007. (Pubitemid 46652571)
7. Yang ZG, Chen AQ and Liu B: Antiproliferation and apoptosis induced by evodiamine in human colorectal carcinoma cells (COLO-205). Chem Biodivers 6: 924-933, 2009.
8. Chen MC, Yu CH, Wang SW, et al: Anti-proliferative effects of evodiamine on human thyroid cancer cell line ARO. J Cell Biochem 110: 1495-1503, 2010.
9. Hsia SM, Su JC, Wang KL and Wang PS: Effects of evodiamine on the expression and secretion of vascular endothelial growth factor in human breast cancer cells. Clin Mol Med 1: 8-13, 2010.
10. Jiang J and Hu C: Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa. Molecules 14: 1852-1859, 2009.
11. Li-Weber M: Targeting apoptosis pathways in cancer by Chinese medicine. Cancer Lett: Aug 2, 2010 (Epub ahead of print).
12. Huang YC, Guh JH and Teng CM: Induction of mitotic arrest and apoptosis by evodiamine in human leukemic T-lymphocytes. Life Sci 75: 35-49, 2004.
13. Huang DM, Guh JH, Huang YT, Chueh SC, Chiang PC and Teng CM: Induction of mitotic arrest and apoptosis in human prostate cancer PC-3 cells by evodiamine. J Urol 173: 256-261, 2005.
14. King KL and Cidlowski JA: Cell cycle and apoptosis: common pathways to life and death. Cell Biochem 58: 175-180, 1995.
15. Hartwell LH and Weinert TA: Checkpoints: controls that ensure the order of cell cycle events. Science 246: 629-634, 1989. (Pubitemid 19283354)
16. Tao W, South VJ, Zhang Y, et al: Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Cancer Cell 8: 49-59, 2005. (Pubitemid 40991814)
17. Vogel C, Kienitz A, Müller R and Bastians H: The mitotic spindle checkpoint is a critical determinant for topoisomerase-based chemotherapy. J Biol Chem 280: 4025-4028, 2005. (Pubitemid 40288565)
18. Stolz A, Vogel C, Schneider V, et al: Pharmacologic abrogation of the mitotic spindle checkpoint by an indolocarbazole discovered by cellular screening efficiently kills cancer cells. Cancer Res 69: 3874-3883, 2009.
19. Jordan MA and Wilson L: Microtubules as a target for anticancer drugs. Nat Rev Cancer 4: 253-265, 2004. (Pubitemid 38525281)
20. Sudo T, Nitta M, Saya H and Ueno NT: Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint. Cancer Res 64: 2502-2508, 2004. (Pubitemid 38523906)
21. Shi J, Orth JD and Mitchison T: Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5. Cancer Res 68: 3269-3276, 2008.
22. Lowe SW and Lin AW: Apoptosis in cancer. Carcinogenesis 21: 485-495, 2000. (Pubitemid 30137934)
23. Whitfield ML, Sherlock G, Saldanha AJ, et al: Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 6: 1977-2000, 2002. (Pubitemid 34651487)
24. Suzuki K, Hino M, Kutsuna H, Hato F, Sakamoto C and Takahashi T: Selective activation of p38 mitogen-activated protein kinase cascade in human neutrophils stimulated by IL-1β. J Immunol 167: 5940-5947, 2001. (Pubitemid 33062790)
25. Yang J, Wu LJ, Tashino S, Onodera S and Ikejima T: Reactive oxygen species and nitric oxide regulate mitochondria-dependent apoptosis and autophagy in evodiamine-treated human cervix carcinoma HeLa cells. Free Radic Res 42: 492-504, 2008. (Pubitemid 351935163)
26. Zhang C, Fan X, Xu X, Yang X, Wang X and Liang HP: Evodiamine induces caspase-dependent apoptosis and S phase arrest in human colon lovo cells. Anticancer Drugs 21: 766-776, 2010.
27. Musacchio A and Salmon ED: The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8: 379-393, 2007. (Pubitemid 46643240)
28. Brito DA, Yang Z and Rieder CL: Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied. J Cell Biol 182: 623-629, 2008.
29. Chen JG, Yang CPH, Cammer M and Horwitz SB: Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res 63: 7891-7899, 2003. (Pubitemid 37466724)
30. Darzynkiewicz Z, Gong J, Juan G, Ardelt B and Traganos F: Cytometry of cyclin proteins. Cytometry 25: 1-13, 1996. (Pubitemid 26298338)
31. Wolf F, Wandke C, Isenberg N and Geley S: Dose-dependent effects of stable cyclin B1 on progression through mitosis in human cells. EMBO J 25: 2802-2813, 2006. (Pubitemid 43980387)
32. Huang H, Zhang Y, Liu X, Li Z, Xu W, He S, Huang Y and Zhang H: Acid sphingomyelinase contributes to Evodiamine-induced apoptosis in human gastric cancer SGC-7901 cells. DNA Cell Biol 30: 407-412, 2011.
33. Zhang Y, Wu LJ, Tashiro S, Onodera S and Ikejima T: Intra-cellular regulation of evodiamine-induced A375-S2 cell death. Biol Pharm Bull 26: 1543-1547, 2003. (Pubitemid 41699632)
34. Takada Y, Kobayashi Y and Aggarwal BB: Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. J Biol Chem 280: 17203-17212, 2005. (Pubitemid 41389187)
35. Wang C, Li S and Wang MW: Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF-kappaB signaling pathways and augmented by ubiquitin-proteasome inhibition. Toxicol In Vitro 24: 898-904, 2010.
36. Chan AL, Chang WS, Chen LM, Lee CM, Chen CE, Lin CM and Hwang JL: Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity. Molecules 14: 1342-1352, 2009.